Brief: Sedana Medical Submits Market Approval Application For Drug Sedaconda
Nov 27 (Reuters) - Sedana Medical AB (publ) SEDANA.ST :
* SEDANA MEDICAL SUBMITS MARKET APPROVAL APPLICATION FOR THE
DRUG
SEDACONDA
* EXPECTS AN APPROVAL IN SECOND HALF OF 2021.
* IN UNITED KINGDOM APPLICATION WILL BE SUBMITTED SEPARATELY
IN Q1
OF 2021
* IN SWITZERLAND APPLICATION WILL BE SUBMITTED IN 2021
Source text for Eikon: ID:nWkr6ZVQm1
Further company coverage: SEDANA.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Sedana Medical AB (publ)
See all newsSweden's Sedana Medical Q3 sales rise as growth returns
Brief: Sedana Medical Announces PDUFA Target Action Date
Brief: Sedana Medical Announces FDA Acceptance For Review Of Its New Drug Application In U.S.
Sweden's Sedana Medical Q2 sales flat, EBITDA loss narrows
Brief: Sedana Medical Q2 EBITDA Loss Narrows To SEK 1.9 Mln